PGP and chronic myelogenous leukemia, BCR-ABL1 positive: Our hypothesis was supported by Galimberti et al., (2005) who observed 3 chronic-phase CML patients which were progressing after remission in the early period of therapy, all of which showed increased P-gp expression 3 months earlier.